Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astellas, Astrazeneca, Biontech SE, Biosyngen, Bristol Meyers, Celltrion, Daewoong, Gracell. Hutchmed, Junshi, Oricell, Takeda.